The Latest Breaking News from Corvus Pharmaceuticals

Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022

Upgrades

Benzinga · Oct 7, 2022

Recap: Corvus Pharmaceuticals Q4 Earnings

Corvus Pharmaceuticals (NASDAQ:CRVS) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · Mar 10, 2022

A Preview Of Corvus Pharmaceuticals's Earnings

Corvus Pharmaceuticals (NASDAQ:CRVS) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that Corvus Pharmaceuticals will report an earnings per share (EPS) of $-0.19.

Benzinga · Mar 9, 2022